Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/31/2005US20050070465 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon
03/31/2005US20050070017 Adenoviral vaccine composition for use in prevention and treatment of viral infection; viricides; veterinary medicine
03/31/2005US20050070014 Method of expressing foreign gene in kidney
03/31/2005US20050070002 Histidine phosphatase interacting protein with 120kd
03/31/2005US20050069990 R2D2: an enzyme of RNA silencing
03/31/2005US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin
03/31/2005US20050069987 Engineered nerve growth factor for use as tool in prevention and treatment of obesity
03/31/2005US20050069986 Nucleotide sequences coding histonw actyltransferase inhibitor for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; gene expression inhibition
03/31/2005US20050069985 Assay methods and amelioration of muscular dystrophy symptoms
03/31/2005US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders
03/31/2005US20050069981 Human vascular IBP-like growth factor
03/31/2005US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents
03/31/2005US20050069979 Cell culture process
03/31/2005US20050069977 Antimicrobial proteins, genes encoding the proteins and method of using the same
03/31/2005US20050069976 Protein-coupled receptor
03/31/2005US20050069968 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay
03/31/2005US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
03/31/2005US20050069948 Using suppressor of early growth response-1 (Egr-1) protein as tool in treatment of kidney disorders
03/31/2005US20050069945 Human chemotactic cytokine I polypeptides
03/31/2005US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing
03/31/2005US20050069943 101 human secreted proteins
03/31/2005US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter
03/31/2005US20050069940 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
03/31/2005US20050069930 Ring finger protein 43 for use as diagnostic indicator of cell proliferative disorders; antitumor agents; RNA interference; drug screening
03/31/2005US20050069924 Differentially methylated sequences in pancreatic cancer
03/31/2005US20050069922 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus
03/31/2005US20050069919 Novel human secreted proteins and polynucleotides encoding the same
03/31/2005US20050069918 Using jun activation domain-binding protein 1 (JAB-1 protein) as diagnostic and prognostic tool for treatment and prevention of cell proliferative disorders of breast and lung
03/31/2005US20050069915 Antibodies that bind human Dickkopf-1 proteins
03/31/2005US20050069914 Novel glycoproteins and methods of use thereof
03/31/2005US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling
03/31/2005US20050069894 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation
03/31/2005US20050069889 Novel metastasis suppressor gene on human chromosome 8
03/31/2005US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
03/31/2005US20050069887 Derived from Thermococcus; thermostability; sequencing; kits
03/31/2005US20050069883 Melanin-concentrating hormone receptor antagonist binding protein
03/31/2005US20050069882 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069875 Using CD109 region specific primer as tool in diagnosis, prevention and treatment of thrombocytopenia
03/31/2005US20050069873 Nucleotide sequences coding insulin like growth factor binding protein-3 (IGFBP-3) receptor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
03/31/2005US20050069872 Mutated aqp, method for detecting cancer using the same, dna chip having oligonucleotides of said mutated aqp sequence
03/31/2005US20050069871 Polypeptide-human zinc finger protein fpm315-17 and the polynucleotide encoding it
03/31/2005US20050069870 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics
03/31/2005US20050069869 Nucleotide sequences coding severe acute respiratory syndrome (SARS) spike glycoprotein for use as tool in development of immunoglobulins for prevention and treatment of respiratory system disorders; immunotherapy; imunodiagnostics
03/31/2005US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
03/31/2005US20050069865 Synthetic hcv envelope proteins and their use for vaccination
03/31/2005US20050069561 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54.
03/31/2005US20050069559 Lawsonia intracellularis vaccine
03/31/2005US20050069558 Machine readable media embedded in three-dimensional matrix; severe acute respiaroty system; crystal structure polypeptide; detection; drug design
03/31/2005US20050069557 A protein neuroglobin derived from neuronal tissue; binging, storage oxygen; therapy for central nervous system disorders
03/31/2005US20050069556 Serology display library; analyzing autologous tumor antigen; drug design; antitumor vaccine containing antigen
03/31/2005US20050069553 Domain which targets Rho protein; anticancer agents
03/31/2005US20050069547 Binding protein; therapy for bone tumors
03/31/2005US20050069544 Pharmaceutical composition and a method of treatment
03/31/2005US20050069537 Stimulants of survival of cells; binding of cellular adhesion molecular; prevent apoptosis
03/31/2005US20050069536 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier
03/31/2005US20050069530 A peptide having the amino acid sequence (SEQ ID NO: 10; enzyme inhibitor of both cystolic and secretory phospholipase A2 (cPLA2 and (sPLA2) activity; antiinflammatory, -ischemic,-carcinogenic agents; rheumatic diseases; acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity
03/31/2005US20050069523 Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)
03/31/2005US20050069521 Enhancing the circulating half-life of interleukin-2 proteins
03/31/2005US20050069494 Polypeptide; magnetic resonance imaging; diagnosis of cancer, osteoarthritis, infections, oral disease, rheumatic diseaeses, antiarthritic agents , cardiovascular disorders
03/31/2005DE10341272A1 Preparing genetically modified Blakeslea, useful for preparation of carotenoids, useful as food additives, cosmetics or pharmaceuticals, comprises transformation, optional homokaryotizing, and selection
03/31/2005DE10338464A1 Using RNA-peptide conjugates for specific gene regulation, useful e.g. for treatment and diagnosis of tumors, provides high transfection efficiency in both isolated cells and organisms
03/31/2005CA2540180A1 Banana resistance genes and uses thereof
03/31/2005CA2540155A1 Excretable reporter systems
03/31/2005CA2540103A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization
03/31/2005CA2539789A1 Peptide originating in hepatitis c virus
03/31/2005CA2539664A1 Rho antibody and tag to purify cell surface proteins
03/31/2005CA2539457A1 Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
03/31/2005CA2539437A1 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom
03/31/2005CA2539270A1 Immunogen
03/31/2005CA2539253A1 Albumin-binding derivatives of therapeutic peptides
03/31/2005CA2539127A1 Receptor
03/31/2005CA2539116A1 Cripto antagonism of activin and tgf-b signaling
03/31/2005CA2539074A1 Campylobacter polypeptides and methods of use
03/31/2005CA2538999A1 Regulation of cardiac contractility and heart failure propensity
03/31/2005CA2538998A1 Large scale preparation of alpha-1 proteinase inhibitor and use thereof
03/31/2005CA2538794A1 Vaccine for treatment and prevention of herpes simplex virus infection
03/31/2005CA2535866A1 Methods and compositions for enhanced plant cell transformation
03/31/2005CA2532831A1 Host defense factor x (hdfx)
03/31/2005CA2532130A1 Diagnostic method for brain damage-related disorders
03/31/2005CA2523657A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
03/30/2005WO2005033704A1 Immunoassay
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518933A1 Vectors and methods for gene transfer to cells
03/30/2005EP1518931A1 Use of P-selectin glycoprotein ligand-1 (PSGL-1) and fragments thereof for the inhibition of thrombosis
03/30/2005EP1518930A2 Methods and compositions for inhibiting neoplastic cell growth
03/30/2005EP1518929A1 Novel genes
03/30/2005EP1518927A2 Optimization of immunomodulatory properties of genetic vaccines
03/30/2005EP1518863A1 Antibodies modulating the activity of equine chorionic gonadotropin.
03/30/2005EP1518558A2 Vaccine against infection with Actinobacillus pleuropneumoniae comprising purified ApxIV toxin
03/30/2005EP1518121A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic
03/30/2005EP1517998A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
03/30/2005EP1517923A2 Compositions and methods for inhibiting microbial adhesion
03/30/2005EP1517919A2 Marked peptides having affinity for a phospholipid and uses
03/30/2005EP1517918A2 Peptides having affinity for a phospholipid and uses
03/30/2005EP1517917A2 Human erg2 potassium channel
03/30/2005EP1517916A2 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods
03/30/2005EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
1 ... 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 ... 2916